ID   AFAP1_HUMAN             Reviewed;         730 AA.
AC   Q8N556; A8K442; B4DMU2; E9PDT7; Q59EY5; Q9HBY1;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 2.
DT   18-JUN-2025, entry version 162.
DE   RecName: Full=Actin filament-associated protein 1;
DE   AltName: Full=110 kDa actin filament-associated protein;
DE            Short=AFAP-110;
GN   Name=AFAP1; Synonyms=AFAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH SRC, PHOSPHORYLATION BY SRC, AND MUTAGENESIS OF PRO-71;
RP   PRO-77; TYR-93; TYR-94; TYR-125; TYR-451 AND TYR-453.
RC   TISSUE=Lung;
RX   PubMed=15485829; DOI=10.1074/jbc.m406880200;
RA   Han B., Bai X.H., Lodyga M., Xu J., Yang B.B., Keshavjee S., Post M.,
RA   Liu M.;
RT   "Conversion of mechanical force into biochemical signaling.";
RL   J. Biol. Chem. 279:54793-54801(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   CYS-403.
RC   TISSUE=Brain, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT CYS-403.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 93-730 (ISOFORM 1), AND VARIANT
RP   MET-518.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   TISSUE SPECIFICITY, AND KNOCKDOWN IN MDA-MB-231 CELLS.
RX   PubMed=17520695; DOI=10.1002/jcp.21143;
RA   Dorfleutner A., Stehlik C., Zhang J., Gallick G.E., Flynn D.C.;
RT   "AFAP-110 is required for actin stress fiber formation and cell adhesion in
RT   MDA-MB-231 breast cancer cells.";
RL   J. Cell. Physiol. 213:740-749(2007).
RN   [8]
RP   TISSUE SPECIFICITY, AND POSSIBLE FUNCTION IN PROSTATE CANCER PROGRESSION.
RX   PubMed=17885682; DOI=10.1172/jci30710;
RA   Zhang J., Park S.I., Artime M.C., Summy J.M., Shah A.N., Bomser J.A.,
RA   Dorfleutner A., Flynn D.C., Gallick G.E.;
RT   "AFAP-110 is overexpressed in prostate cancer and contributes to
RT   tumorigenic growth by regulating focal contacts.";
RL   J. Clin. Invest. 117:2962-2973(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282; SER-283; SER-664;
RP   SER-665; SER-668; SER-679 AND SER-687, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548 AND SER-668, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-668, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-668, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-668, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Can cross-link actin filaments into both network and bundle
CC       structures (By similarity). May modulate changes in actin filament
CC       integrity and induce lamellipodia formation. May function as an adapter
CC       molecule that links other proteins, such as SRC and PKC to the actin
CC       cytoskeleton. Seems to play a role in the development and progression
CC       of prostate adenocarcinoma by regulating cell-matrix adhesions and
CC       migration in the cancer cells. {ECO:0000250,
CC       ECO:0000269|PubMed:15485829}.
CC   -!- SUBUNIT: Monomer and homomultimer. Interacts via its C-terminus with F-
CC       actin; probably involving AFAP1 multimers (By similarity). Interacts
CC       with activated SRC SH3-SH2 domains. Interacts via its PH 1 domain with
CC       PRKCA, PRKCB and PRKCI (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, stress fiber
CC       {ECO:0000269|PubMed:15485829}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N556-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N556-2; Sequence=VSP_044838;
CC   -!- TISSUE SPECIFICITY: Low expression in normal breast epithelial cell
CC       line MCF-10A and in tumorigenic breast cancer cell lines MCF-7, T-47D
CC       and ZR-75-1. Highly expressed in the invasive breast cancer cell lines
CC       MDA-MB-231 and MDA-MB-435. Overexpressed in prostate carcinoma.
CC       {ECO:0000269|PubMed:17520695, ECO:0000269|PubMed:17885682}.
CC   -!- PTM: Phosphorylated on tyrosine residues by SRC.
CC       {ECO:0000269|PubMed:15485829}.
CC   -!- MISCELLANEOUS: Knockdown in MDA-MB-231 cells resulted in loss of actin
CC       stress fibers, decreased adhesion and spreading on fibronectin.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF188700; AAG17055.1; -; mRNA.
DR   EMBL; AK290807; BAF83496.1; -; mRNA.
DR   EMBL; AK297631; BAG60004.1; -; mRNA.
DR   EMBL; AC004169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC097381; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112254; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC141931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC144451; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032777; AAH32777.1; -; mRNA.
DR   EMBL; AB209676; BAD92913.1; -; mRNA.
DR   CCDS; CCDS3397.1; -. [Q8N556-1]
DR   CCDS; CCDS47010.1; -. [Q8N556-2]
DR   RefSeq; NP_001128119.1; NM_001134647.2. [Q8N556-2]
DR   RefSeq; NP_001358019.1; NM_001371090.1. [Q8N556-1]
DR   RefSeq; NP_001358020.1; NM_001371091.1. [Q8N556-1]
DR   RefSeq; NP_940997.1; NM_198595.3. [Q8N556-1]
DR   RefSeq; XP_011511846.1; XM_011513544.4. [Q8N556-2]
DR   RefSeq; XP_054206664.1; XM_054350689.1. [Q8N556-2]
DR   AlphaFoldDB; Q8N556; -.
DR   SMR; Q8N556; -.
DR   BioGRID; 121895; 75.
DR   FunCoup; Q8N556; 678.
DR   IntAct; Q8N556; 46.
DR   STRING; 9606.ENSP00000410689; -.
DR   GlyGen; Q8N556; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8N556; -.
DR   PhosphoSitePlus; Q8N556; -.
DR   BioMuta; AFAP1; -.
DR   DMDM; 166919564; -.
DR   jPOST; Q8N556; -.
DR   MassIVE; Q8N556; -.
DR   PeptideAtlas; Q8N556; -.
DR   ProteomicsDB; 19745; -.
DR   ProteomicsDB; 72004; -. [Q8N556-1]
DR   Pumba; Q8N556; -.
DR   Antibodypedia; 2882; 517 antibodies from 32 providers.
DR   DNASU; 60312; -.
DR   Ensembl; ENST00000358461.6; ENSP00000351245.2; ENSG00000196526.11. [Q8N556-1]
DR   Ensembl; ENST00000360265.9; ENSP00000353402.4; ENSG00000196526.11. [Q8N556-1]
DR   Ensembl; ENST00000382543.4; ENSP00000371983.3; ENSG00000196526.11. [Q8N556-2]
DR   Ensembl; ENST00000420658.6; ENSP00000410689.1; ENSG00000196526.11. [Q8N556-2]
DR   GeneID; 60312; -.
DR   KEGG; hsa:60312; -.
DR   MANE-Select; ENST00000420658.6; ENSP00000410689.1; NM_001134647.2; NP_001128119.1. [Q8N556-2]
DR   UCSC; uc003gkg.2; human. [Q8N556-1]
DR   AGR; HGNC:24017; -.
DR   CTD; 60312; -.
DR   DisGeNET; 60312; -.
DR   GeneCards; AFAP1; -.
DR   HGNC; HGNC:24017; AFAP1.
DR   HPA; ENSG00000196526; Low tissue specificity.
DR   MIM; 608252; gene.
DR   OpenTargets; ENSG00000196526; -.
DR   VEuPathDB; HostDB:ENSG00000196526; -.
DR   eggNOG; ENOG502QQI1; Eukaryota.
DR   GeneTree; ENSGT00950000183067; -.
DR   HOGENOM; CLU_014418_2_0_1; -.
DR   InParanoid; Q8N556; -.
DR   OMA; THMASIP; -.
DR   OrthoDB; 5970758at2759; -.
DR   PAN-GO; Q8N556; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q8N556; -.
DR   PathwayCommons; Q8N556; -.
DR   SignaLink; Q8N556; -.
DR   SIGNOR; Q8N556; -.
DR   BioGRID-ORCS; 60312; 9 hits in 1141 CRISPR screens.
DR   ChiTaRS; AFAP1; human.
DR   GeneWiki; AFAP1; -.
DR   GenomeRNAi; 60312; -.
DR   Pharos; Q8N556; Tbio.
DR   PRO; PR:Q8N556; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q8N556; protein.
DR   Bgee; ENSG00000196526; Expressed in stromal cell of endometrium and 125 other cell types or tissues.
DR   ExpressionAtlas; Q8N556; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005925; C:focal adhesion; IDA:HPA.
DR   GO; GO:0001725; C:stress fiber; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0009966; P:regulation of signal transduction; IBA:GO_Central.
DR   CDD; cd13306; PH1_AFAP; 1.
DR   CDD; cd13307; PH2_AFAP; 1.
DR   FunFam; 2.30.29.30:FF:000122; Actin filament associated protein 1; 1.
DR   FunFam; 2.30.29.30:FF:000020; Actin filament-associated protein 1-like 2 isoform 1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   InterPro; IPR030113; AFAP.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR14338:SF8; ACTIN FILAMENT-ASSOCIATED PROTEIN 1; 1.
DR   PANTHER; PTHR14338; ACTIN FILAMENT-ASSOCIATED PROTEIN 1 FAMILY MEMBER; 1.
DR   Pfam; PF00169; PH; 2.
DR   SMART; SM00233; PH; 2.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   neXtProt; NX_Q8N556; -.
DR   PharmGKB; PA162375733; -.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat.
FT   CHAIN           1..730
FT                   /note="Actin filament-associated protein 1"
FT                   /id="PRO_0000317658"
FT   DOMAIN          153..249
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          347..441
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          47..91
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          119..140
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          252..292
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          512..537
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          594..637
FT                   /note="Interaction with F-actin"
FT                   /evidence="ECO:0000250"
FT   COILED          557..648
FT                   /evidence="ECO:0000255"
FT   MOTIF           71..74
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000250"
FT   MOTIF           94..97
FT                   /note="SH2-binding 1"
FT                   /evidence="ECO:0000250"
FT   MOTIF           451..456
FT                   /note="SH2-binding 2"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        60..85
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        268..283
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         282
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         548
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         664
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         665
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         668
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         675
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YS6"
FT   MOD_RES         679
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         510
FT                   /note="S -> SWEPEDGFPASCSRGLGEEVLYDNAGLYDNLPPPHIFARYSPADRKA
FT                   SRLSADKLSSNHYKYPASAQSVTNTSSVGRASLGLNSQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044838"
FT   VARIANT         403
FT                   /note="S -> C (in dbSNP:rs28406288)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_038578"
FT   VARIANT         518
FT                   /note="V -> M (in dbSNP:rs41264705)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_038579"
FT   MUTAGEN         71
FT                   /note="P->A: Decreased tyrosine phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   MUTAGEN         77
FT                   /note="P->A: No effect on tyrosine phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   MUTAGEN         93
FT                   /note="Y->F: Reduces phosphorylation and phosphorylation of
FT                   SRC at Y-416; when associated with F-94; F-125; F-451 and
FT                   F-453."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   MUTAGEN         94
FT                   /note="Y->F: Reduces phosphorylation and phosphorylation of
FT                   SRC at Y-416; when associated with F-93; F-125; F-451 and
FT                   F-453."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   MUTAGEN         125
FT                   /note="Y->F: Reduces phosphorylation and phosphorylation of
FT                   SRC at Y-416; when associated with F-93; F-94; F-451 and
FT                   F-453."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   MUTAGEN         451
FT                   /note="Y->F: Reduces phosphorylation and phosphorylation of
FT                   SRC at Y-416; when associated with F-93; F-94; F-125 and
FT                   F-453."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   MUTAGEN         453
FT                   /note="Y->F: Reduces phosphorylation and phosphorylation of
FT                   SRC at Y-416; when associated with F-93; F-94; F-125 and
FT                   F-451."
FT                   /evidence="ECO:0000269|PubMed:15485829"
FT   CONFLICT        197
FT                   /note="P -> L (in Ref. 1; AAG17055)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        223
FT                   /note="G -> D (in Ref. 1; AAG17055)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        238
FT                   /note="E -> G (in Ref. 1; AAG17055)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        465
FT                   /note="T -> A (in Ref. 2; BAF83496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        Q8N556-2:561
FT                   /note="A -> V (in Ref. 2; BAG60004)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   730 AA;  80725 MW;  4E916BB4F82F5547 CRC64;
     MEELIVELRL FLELLDHEYL TSTVREKKAV ITNILLRIQS SKGFDVKDHA QKQETANSLP
     APPQMPLPEI PQPWLPPDSG PPPLPTSSLP EGYYEEAVPL SPGKAPEYIT SNYDSDAMSS
     SYESYDEEEE DGKGKKTRHQ WPSEEASMDL VKDAKICAFL LRKKRFGQWT KLLCVIKDTK
     LLCYKSSKDQ QPQMELPLQG CNITYIPKDS KKKKHELKIT QQGTDPLVLA VQSKEQAEQW
     LKVIKEAYSG CSGPVDSECP PPPSSPVHKA ELEKKLSSER PSSDGEGVVE NGITTCNGKE
     QVKRKKSSKS EAKGTVSKVT GKKITKIISL GKKKPSTDEQ TSSAEEDVPT CGYLNVLSNS
     RWRERWCRVK DNKLIFHKDR TDLKTHIVSI PLRGCEVIPG LDSKHPLTFR LLRNGQEVAV
     LEASSSEDMG RWIGILLAET GSSTDPEALH YDYIDVEMSA SVIQTAKQTF CFMNRRVISA
     NPYLGGTSNG YAHPSGTALH YDDVPCINGS LKGKKPPVAS NGVTGKGKTL SSQPKKADPA
     AVVKRTGSNA AQYKYGKNRV EADAKRLQTK EEELLKRKEA LRNRLAQLRK ERKDLRAAIE
     VNAGRKPQAI LEEKLKQLEE ECRQKEAERV SLELELTEVK ESLKKALAGG VTLGLAIEPK
     SGTSSPQSPV FRHRTLENSP ISSCDTSDTE GPVPVNSAAV LKKSQAAPGS SPCRGHVLRK
     AKEWELKNGT
//
